CagriSema Dual-Pathway Metabolic Signaling Compound CagriSema combines two investigational molecules Cagrilintide (amylin analogue) and Semaglutide (GLP-1 receptor agonist), designed to influence key metabolic and appetite-regulating pathways. Current US$ 28.27 Min. order: 1 piece ★★★★★ 4.6 (88 reviews) Sold : Login>>
Current Status of Therapeutic Peptides for the Management of Diabetes Mellitus | International Journal of Peptide Research and Therapeutics US$ 28.23 Min. order: 1 piece ★★★★★ 4.6 (143 reviews) Sold : Login>>
cAMP analog structures and peptide sequence alignments US$ 29.70 Min. order: 1 piece ★★★★★ 4.2 (271 reviews) Sold : Login>>
Cagrilintide: The Next-Gen Peptide for Weight Loss and Satiety US$ 24.17 Min. order: 1 piece ★★★★★ 4.5 (61 reviews) Sold : Login>>
Identification and utility exploration of a highly potent and long-acting bullfrog GLP-1 analogue in GLP-1 and amylin combination therapy US$ 20.85 Min. order: 1 piece ★★★★★ 4.1 (211 reviews) Sold : Login>>
Cagrilintide/Semaglutide Blend 5+5mg for Sale US$ 28.67 Min. order: 1 piece ★★★★★ 4.5 (207 reviews) Sold : Login>>